Skip to content
naulon
Get started

Not checked for notices yet.

Serological response to a third booster dose of BNT162b2 COVID‐19 vaccine among seronegative cancer patients

Einat Shacham Shmueli, Yaacov R. Lawrence, Galia Rahav and 5 more

Cancer Reports · 2022

doi:10.1002/cnr2.1645

References 7

  1. 1.
    Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer · 2021
    No notice
  2. 2.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  3. 3.
    Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer · 2021
    No notice
  4. 4.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  5. 5.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  6. 6.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  7. 7.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.